MakCHS Publications

Found 80 results
Author Keyword Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
N. Sewankambo, Academic medicine and global health responsibilities., BMJ (Clinical research ed.), vol. 329, no. 7469, pp. 752-3, 2004.
M. I. Schmidt and Duncan, B. B., Academic medicine as a resource for global health: the case of Brazil., BMJ (Clinical research ed.), vol. 329, no. 7469, pp. 753-4, 2004.
R. K. Wanyenze, Nawavvu, C., Namale, A. S., Mayanja, B., Bunnell, R., Abang, B., Amanyire, G., Sewankambo, N. K., and Kamya, M. R., Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals., Bulletin of the World Health Organization, vol. 86, no. 4, pp. 302-9, 2008.
D. Nakanjako, Kamya, M., Daniel, K., Mayanja-Kizza, H., Freers, J., Whalen, C., and Katabira, E., Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda., AIDS and behavior, vol. 11, no. 5, pp. 753-8, 2007.
P. Bagasha, Nakwagala, F., Kwizera, A., Ssekasanvu, E., and Kalyesubula, R., Acute kidney injury among adult patients with sepsis in a low-income country: clinical patterns and short-term outcomes., BMC Nephrol, vol. 16, p. 4, 2015.
J. Mugalu, Nakakeeto, M. K., Kiguli, S., and Kaddu-Mulindwa, D. H., Aetiology, risk factors and immediate outcome of bacteriologically confirmed neonatal septicaemia in Mulago hospital, Uganda., African health sciences, vol. 6, no. 2, pp. 120-6, 2006.
R. J. Kelly, Gray, R. H., Sewankambo, N. K., Serwadda, D., Wabwire-Mangen, F., Lutalo, T., and Wawer, M. J., Age differences in sexual partners and risk of HIV-1 infection in rural Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 32, no. 4, pp. 446-51, 2003.
R. Kelly, Kiwanuka, N., Wawer, M. J., Serwadda, D., Sewankambo, N. K., Wabwire-Mangen, F., Li, C., Konde-Lule, J. K., Lutalo, T., Makumbi, F., and Gray, R. H., Age of male circumcision and risk of prevalent HIV infection in rural Uganda., AIDS (London, England), vol. 13, no. 3, pp. 399-405, 1999.
C. Thorne and Newell, M. - L., Are girls more at risk of intrauterine-acquired HIV infection than boys?, AIDS (London, England), vol. 18, no. 2, pp. 344-7, 2004.
H. Brahmbhatt, Sullivan, D., Kigozi, G., Askin, F., Wabwire-Mangenm, F., Serwadda, D., Sewankambo, N., Wawer, M., and Gray, R., Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality., Journal of acquired immune deficiency syndromes (1999), vol. 47, no. 4, pp. 472-6, 2008.
C. S. Hirsch, Toossi, Z., Johnson, J. L., Luzze, H., Ntambi, L., Peters, P., McHugh, M., Okwera, A., Joloba, M., Mugyenyi, P., Mugerwa, R. D., Terebuh, P., and Ellner, J. J., Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis., The Journal of infectious diseases, vol. 183, no. 5, pp. 779-88, 2001.
S. E. Mshana, Joloba, M., Kakooza, A., and Kaddu-Mulindwa, D., Campylobacter spp among children with acute diarrhea attending Mulago hospital in Kampala--Uganda., African health sciences, vol. 9, no. 3, pp. 201-5, 2009.
R. G. White, Orroth, K. K., Korenromp, E. L., Bakker, R., Wambura, M., Sewankambo, N. K., Gray, R. H., Kamali, A., Whitworth, J. A. G., Grosskurth, H., Habbema, D. J. F., and Hayes, R. J., Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study., Journal of acquired immune deficiency syndromes (1999), vol. 37, no. 4, pp. 1500-13, 2004.
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
B. Castelnuovo, Manabe, Y. C., Kiragga, A., Kamya, M., Easterbrook, P., and Kambugu, A., Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 49, no. 6, pp. 965-72, 2009.
E. H. Geng, Neilands, T. B., Thièbaut, R., Bwana, M. Bosco, Nash, D., Moore, R. D., Wood, R., Zannou, D. Marcel, Althoff, K. N., Lim, P. Lian, Nachega, J. B., Easterbrook, P. J., Kambugu, A., Little, F., Nakigozi, G., Nakanjako, D., Kiggundu, V., Li, P. Chung Ki, Bangsberg, D. R., Fox, M. P., Prozesky, H. W., Hunt, P. W., Davies, M. - A., Reynolds, S. J., Egger, M., Yiannoutsos, C. T., Vittinghoff, E. V., Deeks, S. G., and Martin, J. N., CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa., Int J Epidemiol, vol. 44, no. 1, pp. 251-63, 2015.
M. J. Wawer, Makumbi, F., Kigozi, G., Serwadda, D., Watya, S., Nalugoda, F., Buwembo, D., Ssempijja, V., Kiwanuka, N., Moulton, L. H., Sewankambo, N. K., Reynolds, S. J., Quinn, T. C., Opendi, P., Iga, B., Ridzon, R., Laeyendecker, O., and Gray, R. H., Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial., Lancet, vol. 374, no. 9685, pp. 229-37, 2009.
H. Yoshimine, Oishi, K., Mubiru, F., Nalwoga, H., Takahashi, H., Amano, H., Ombasi, P., Watanabe, K., Joloba, M., Aisu, T., Ahmed, K., Shimada, M., Mugerwa, R., and Nagatake, T., Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia., The American journal of tropical medicine and hygiene, vol. 64, no. 3-4, pp. 172-7, 2001.
S. Karle, Planque, S., Nishiyama, Y., Taguchi, H., Zhou, Y. - X., Salas, M., Lake, D., Thiagarajan, P., Arnett, F., Hanson, C. V., and Paul, S., Cross-clade HIV-1 neutralization by an antibody fragment from a lupus phage display library., AIDS (London, England), vol. 18, no. 2, pp. 329-31, 2004.
R. H. Gray, Li, X., Wawer, M. J., Serwadda, D., Sewankambo, N. K., Wabwire-Mangen, F., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Robb, M., and Quinn, T. C., Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda., The Journal of infectious diseases, vol. 189, no. 7, pp. 1209-15, 2004.
R. S. Wallis, Patil, S., Cheon, S. H., Edmonds, K., Phillips, M., Perkins, M. D., Joloba, M., Namale, A., Johnson, J. L., Teixeira, L., Dietze, R., Siddiqi, S., Mugerwa, R. D., Eisenach, K., and Ellner, J. J., Drug tolerance in Mycobacterium tuberculosis., Antimicrobial agents and chemotherapy, vol. 43, no. 11, pp. 2600-6, 1999.
M. J. Wawer, Serwadda, D., Musgrave, S. D., Konde-Lule, J. K., Musagara, M., and Sewankambo, N. K., Dynamics of spread of HIV-I infection in a rural district of Uganda., BMJ (Clinical research ed.), vol. 303, no. 6813, pp. 1303-6, 1991.
N. Kiwanuka, Laeyendecker, O., Robb, M., Kigozi, G., Arroyo, M., McCutchan, F., Eller, L. A., Eller, M., Makumbi, F., Birx, D., Wabwire-Mangen, F., Serwadda, D., Sewankambo, N. K., Quinn, T. C., Wawer, M., and Gray, R., Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection., The Journal of infectious diseases, vol. 197, no. 5, pp. 707-13, 2008.
M. G. Kiddugavu, Kiwanuka, N., Wawer, M. J., Serwadda, D., Sewankambo, N. K., Wabwire-Mangen, F., Makumbi, F., Li, X., Reynolds, S. J., Quinn, T. C., and Gray, R. H., Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda., Sexually transmitted diseases, vol. 32, no. 1, pp. 1-6, 2005.
M. J. Boyle, Jagannathan, P., Bowen, K., McIntyre, T. I., Vance, H. M., Farrington, L. A., Greenhouse, B., Nankya, F., Rek, J., Katureebe, A., Arinaitwe, E., Dorsey, G., Kamya, M. R., and Feeney, M. E., Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations., J Infect Dis, vol. 212, no. 3, pp. 416-25, 2015.
H. Brahmbhatt, Kigozi, G., Wabwire-Mangen, F., Serwadda, D., Sewankambo, N., Lutalo, T., Wawer, M. J., Abramowsky, C., Sullivan, D., and Gray, R., The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda., AIDS (London, England), vol. 17, no. 17, pp. 2539-41, 2003.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
F. Lutwama, Serwadda, R., Mayanja-Kizza, H., Shihab, H. M., Ronald, A., Kamya, M. R., Thomas, D., Johnson, E., Quinn, T. C., Moore, R. D., and Spacek, L. A., Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy., Journal of acquired immune deficiency syndromes (1999), vol. 48, no. 3, pp. 297-303, 2008.
C. Kigonya, Lutwama, F., and Colebunders, R., Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African woman., International journal of dermatology, vol. 47, no. 1, pp. 102-3, 2008.
M. Wayengera, On the general theory of the origins of retroviruses., Theoretical biology & medical modelling, vol. 7, p. 5, 2010.
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients., AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
C. Acuña-Villaorduña, Ayakaka, I., Dryden-Peterson, S., Nakubulwa, S., Worodria, W., Reilly, N., Hosford, J., Fennelly, K. P., Okwera, A., and Jones-López, E. C., High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study., Am J Trop Med Hyg, vol. 93, no. 1, pp. 73-5, 2015.
F. Bwanga, Disqué, C., Lorenz, M. G., Allerheiligen, V., Worodria, W., Luyombya, A., Najjingo, I., and Weizenegger, M., Higher blood volumes improve the sensitivity of direct PCR diagnosis of blood stream tuberculosis among HIV-positive patients: an observation study., BMC Infect Dis, vol. 15, p. 48, 2015.
M. A. Arroyo, Sateren, W. B., Serwadda, D., Gray, R. H., Wawer, M. J., Sewankambo, N. K., Kiwanuka, N., Kigozi, G., Wabwire-Mangen, F., Eller, M., Eller, L. A., Birx, D. L., Robb, M. L., and McCutchan, F. E., Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 43, no. 4, pp. 440-5, 2006.
K. K. Orroth, Korenromp, E. L., White, R. G., Gavyole, A., Gray, R. H., Muhangi, L., Sewankambo, N. K., Quigley, M., Wawer, M. J., Whitworth, J. A., Grosskurth, H., Habbema, D. J., and Hayes, R. J., Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes., AIDS (London, England), vol. 17, no. 18, pp. 2653-60, 2003.
M. Kiddugavu, Makumbi, F., Wawer, M. J., Serwadda, D., Sewankambo, N. K., Wabwire-Mangen, F., Lutalo, T., Meehan, M., Meehan, M., and Gray, R. H., Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda., AIDS (London, England), vol. 17, no. 2, pp. 233-40, 2003.
C. M. Wheeler, HPV genotypes: implications for worldwide cervical cancer screening and vaccination., The lancet oncology, vol. 11, no. 11, pp. 1013-4, 2010.
D. Serwadda, Gray, R. H., Sewankambo, N. K., Wabwire-Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Ashley Morrow, R., and Wawer, M. J., Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda., The Journal of infectious diseases, vol. 188, no. 10, pp. 1492-7, 2003.
P. Ravn, Demissie, A., Eguale, T., Wondwosson, H., Lein, D., Amoudy, H. A., Mustafa, A. S., Jensen, A. K., Holm, A., Rosenkrands, I., Oftung, F., Olobo, J., von Reyn, F., and Andersen, P., Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis., The Journal of infectious diseases, vol. 179, no. 3, pp. 637-45, 1999.
M. Wayengera, Kajumbula, H., and Byarugaba, W., Identification of restriction endonuclease with potential ability to cleave the HSV-2 genome: inherent potential for biosynthetic versus live recombinant microbicides., Theoretical biology & medical modelling, vol. 5, p. 18, 2008.
G. Chamie, Wandera, B., Marquez, C., Kato-Maeda, M., Kamya, M. R., Havlir, D. V., and Charlebois, E. D., Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach., Trop Med Int Health, vol. 20, no. 4, pp. 537-45, 2015.
M. T. Doherty, Demissie, A., Olobo, J., Wolday, D., Britton, S., Eguale, T., Ravn, P., and Andersen, P., Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients., Journal of clinical microbiology, vol. 40, no. 2, pp. 704-6, 2002.
J. Whitworth, Sewankambo, N. K., and Snewin, V. A., Improving implementation: building research capacity in maternal, neonatal, and child health in Africa., PLoS medicine, vol. 7, no. 7, p. e1000299, 2010.
S. Munier, Borjabad, A., Lemaire, M., Mariot, V., and Hazan, U., In vitro infection of human primary adipose cells with HIV-1: a reassessment., AIDS (London, England), vol. 17, no. 17, pp. 2537-9, 2003.
V. Baraka, Tinto, H., Valea, I., Fitzhenry, R., Delgado-Ratto, C., Mbonye, M. K., Van Overmeir, C., Rosanas-Urgell, A., Van Geertruyden, J. - P., D'Alessandro, U., and Erhart, A., In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso., Antimicrob Agents Chemother, vol. 59, no. 1, pp. 734-7, 2015.
N. Kiwanuka, Gray, R. H., Serwadda, D., Li, X., Sewankambo, N. K., Kigozi, G., Lutalo, T., Nalugoda, F., and Wawer, M. J., The incidence of HIV-1 associated with injections and transfusions in a prospective cohort, Rakai, Uganda., AIDS (London, England), vol. 18, no. 2, pp. 342-4, 2004.
R. S. Wallis, Perkins, M., Phillips, M., Joloba, M., Demchuk, B., Namale, A., Johnson, J. L., Williams, D., Wolski, K., Teixeira, L., Dietze, R., Mugerwa, R. D., Eisenach, K., and Ellner, J. J., Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment., The Journal of infectious diseases, vol. 178, no. 4, pp. 1115-21, 1998.
M. A. Eller, Blom, K. G., Gonzalez, V. D., Eller, L. A., Naluyima, P., Laeyendecker, O., Quinn, T. C., Kiwanuka, N., Serwadda, D., Sewankambo, N. K., Tasseneetrithep, B., Wawer, M. J., Gray, R. H., Marovich, M. A., Michael, N. L., de Souza, M. S., Wabwire-Mangen, F., Robb, M. L., Currier, J. R., and Sandberg, J. K., Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans., PloS one, vol. 6, no. 4, p. e18779, 2011.
C. L. Cooper and Cameron, W. D., Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection., AIDS (London, England), vol. 18, no. 2, pp. 337-8, 2004.
B. Castelnuovo, Nanyonjo, A., Kamya, M., and Ocama, P., Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?, African health sciences, vol. 8, no. 2, pp. 133-4, 2008.
N. Kiwanuka, Robb, M., Kigozi, G., Birx, D., Philips, J., Wabwire-Mangen, F., Wawer, M. J., Nalugoda, F., Sewankambo, N. K., Serwadda, D., and Gray, R. H., Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 36, no. 2, pp. 721-5, 2004.
R. H. Gray, Makumbi, F., Serwadda, D., Lutalo, T., Nalugoda, F., Opendi, P., Kigozi, G., Reynolds, S. J., Sewankambo, N. K., and Wawer, M. J., Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study., BMJ (Clinical research ed.), vol. 335, no. 7612, p. 188, 2007.
C. Mgone, Volmink, J., Coles, D., Makanga, M., Jaffar, S., and Sewankambo, N., Linking research and development to strengthen health systems in Africa., Tropical medicine & international health : TM & IH, vol. 15, no. 12, pp. 1404-6, 2010.
R. H. Gray, Kiwanuka, N., Quinn, T. C., Sewankambo, N. K., Serwadda, D., Mangen, F. W., Lutalo, T., Nalugoda, F., Kelly, R., Meehan, M., Chen, M. Z., Li, C., and Wawer, M. J., Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team., AIDS (London, England), vol. 14, no. 15, pp. 2371-81, 2000.
J. Kagaayi, Dreyfuss, M. L., Kigozi, G., Chen, M. Z., Wabwire-Mangen, F., Serwadda, D., Wawer, M. J., Sewankambo, N. K., Nalugoda, F., Kiwanuka, N., Kiddugavu, M., and Gray, R. H., Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 39, no. 1, pp. 121-4, 2005.
A. D. Redd, Dabitao, D., Bream, J. H., Charvat, B., Laeyendecker, O., Kiwanuka, N., Lutalo, T., Kigozi, G., Tobian, A. A. R., Gamiel, J., Neal, J. D., Oliver, A. E., Margolick, J. B., Sewankambo, N., Reynolds, S. J., Wawer, M. J., Serwadda, D., Gray, R. H., and Quinn, T. C., Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa., Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 16, pp. 6718-23, 2009.
H. Brahmbhatt, Kigozi, G., Wabwire-Mangen, F., Serwadda, D., Lutalo, T., Nalugoda, F., Sewankambo, N., Kiduggavu, M., Wawer, M., and Gray, R., Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 41, no. 4, pp. 504-8, 2006.
R. Colebunders, Moses, K. R., Laurence, J., Shihab, H. M., Semitala, F., Lutwama, F., Bakeera-Kitaka, S., Lynen, L., Spacek, L., Reynolds, S. J., Quinn, T. C., Viner, B., and Mayanja-Kizza, H., A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries., The Lancet infectious diseases, vol. 6, no. 1, pp. 53-9, 2006.
R. S. Wallis, Perkins, M. D., Phillips, M., Joloba, M., Namale, A., Johnson, J. L., Whalen, C. C., Teixeira, L., Demchuk, B., Dietze, R., Mugerwa, R. D., Eisenach, K., and Ellner, J. J., Predicting the outcome of therapy for pulmonary tuberculosis., American journal of respiratory and critical care medicine, vol. 161, no. 4 Pt 1, pp. 1076-80, 2000.
M. Bwakura-Dangarembizi, Musiime, V., Szubert, A. J., Prendergast, A. J., Gomo, Z. A., Thomason, M. J., Musarurwa, C., Mugyenyi, P., Nahirya, P., Kekitiinwa, A., Gibb, D. M., Walker, A. S., and Nathoo, K., Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy., Pediatr Infect Dis J, vol. 34, no. 2, pp. e23-31, 2015.

Pages